Healthy Living/WellnessFDA Clears AstraZeneca's Zurampic For Patients With Gout The U.S. Food and Drug Administration has approved AstraZeneca's Zurampic as a new treatment drug for gout. The drug is used to reduce high levels of uric acid in the blood associated with the disease.by Angela Laguipo
Healthy Living/WellnessFDA Wants To Ban Indoor Tanning For Children Under 18 To Fight Cancerby Alyssa Navarro
Healthy Living/WellnessFDA Approves Genentech Drug Alecensa For ALK-Positive Lung Cancerby Katherine Derla
Healthy Living/WellnessDoctors Dispute FDA Ruling On Device To Remove Uterine Fibroidsby Angela Laguipo
Healthy Living/WellnessGame Changing Syringe That Plugs Bullet Wounds In 20 Seconds Gets FDA Approval For Civilian Useby Alexandra Burlacu
Healthy Living/WellnessNut Butter Tied To Salmonella Outbreak That Sickened 11 In Nine Statesby Angela Laguipo
Healthy Living/WellnessMontana Woman Files Lawsuit Against Costco, Supplier In E. Coli Outbreakby Angela Laguipo
Healthy Living/WellnessFDA Declines Approval Of Opdivo Drug For Expanded Use As Metastatic Melanoma Treatmentby Katherine Derla
South Korea's ICT Exports Hit All-Time Growth Rate of 125.9% in April, Driven by AI Server Chip Demand